loadpatents
Patent applications and USPTO patent grants for Basu; Reetobrata.The latest application filed is for "growth hormone antagonist and anti-cancer composition combination therapy".
Patent | Date |
---|---|
Therapeutic pegylated growth hormone antagonists Grant 11,452,763 - Brody , et al. September 27, 2 | 2022-09-27 |
Methods for treating cancers using fat specific protein 27 (FSP27) compositions Grant 11,426,445 - Kopchick , et al. August 30, 2 | 2022-08-30 |
Growth Hormone Antagonist And Anti-cancer Composition Combination Therapy App 20220040266 - BRODY; Richard S. ;   et al. | 2022-02-10 |
Peptide-based Inhibitors Of Growth Hormone Action And Methods Of Use Thereof App 20210122801 - Holub; Justin M. ;   et al. | 2021-04-29 |
Therapeutic Pegylated Growth Hormone Antagonists App 20200390863 - Brody; Richard S. ;   et al. | 2020-12-17 |
Methods For Treating Cancers Using Fat Specific Protein 27 (fsp27) Compositions App 20200222502 - Kopchick; John ;   et al. | 2020-07-16 |
Method of Treating Cancer and Method of Sensitizing Cancer Cells to the Action of Chemotherapeutic Agents via Growth Hormone Rec App 20190309308 - Kopchick; John J. ;   et al. | 2019-10-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.